James Burke

James Burke

Company: CG Oncology

Job title: Chief Medical Officer

Seminars:

CG0070 for Bladder Cancer 1:00 pm

The data on CG0070 for NMIBC as a single agent will be reviewed The data on CG0070 in combination with pembrolizumab for NMIBC will be reviewed The data on CG0070 plus nivolumab for MIBC will be reviewedRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.